Skip links
Centro de Inovação Teranóstica em Câncer
FAPESP - logo branco oficial 2024 (1)
CancerThCancerThera - Apoio - logo unicamp brancoera - Apoio - logo unicamp branco
CancerThera - Apoio - Hemocentro Unicamp - branco
Cancerthera - Logo-Faculdade-Santa-Casa-SP-branco
CancerThera - Apoio - IQSC USP - branco

Apoio:

FAPESP - logo branco oficial 2024 (1)
Contato
Instagram Facebook Youtube X-twitter Linkedin
CEPID CancerThera
CANCERTHERA - Equipe - Mariana da Cunha Lopes de Lima

Pesquisadora Associada

Medicina Nuclear, UNICAMP

Mariana da Cunha Lopes de Lima

Linhas de Pesquisa

PET/CT em Oncologia

18F-FDG

PET-CT

Tumor

Medicina Nuclear em Nefrourologia

Kidney

99mTc-DTPA

99mTc-DMSA

Produção Científica
  1. Etchebehere E, Andrade R, Camacho M, Lima M, Brink A, Cerci J, Nadel H, Bal C, Rangarajan V, Pfluger T, Kagna O, Alonso O, Begum FK, Mir KB, Magboo VP, Menezes LJ, Paez D, Pascual TN. Validation of Convolutional Neural Networks for Fast Determination of Whole-Body Metabolic Tumor Burden in Pediatric Lymphoma. J Nucl Med Technol. 2022;50:256-262. https://doi.org/ 10.2967/jnmt.121.262900
  2. Santos DF, Takahashi ME, Camacho M,  Lima MCL, Amorim, BJ, Rohren EM, Etchebehere E. Whole-body tumor burden in PET/CT expert review. Clin Transl Imaging 2023;11: 5–22. https://doi.org/10.1007/s40336-022-00517-5
  3. Santos A, Mattiolli A, Carvalheira JB, Ferreira U, Camacho M, Silva C, Costa F, Matheus W, Lima M, Etchebehere E. PSMA whole-body tumor burden in primary staging and biochemical recurrence of prostate cancer. Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):493-500. https://doi.org/10.1007/s00259-020-04981-x
  4. Almeida LS, Araújo ML, Santos AO, Montali da Assumpção LV, Lima ML, Ramos CD, Zantut-Wittmann DE, Etchebehere EC. Head-to-head comparison of F-18 FDG PET/CT in radioidine refractory thyroid cancer patients with elevated versus suppressed TSH levels a pilot study. Heliyon. 2020 Mar 5;6(3):e03450. https://doi.org./10.1016/j.heliyon.2020.e03450
  5. Lima M, Camacho M, Carvalheira JBC, Biggi A, Lima ML, Ciampi J, Salis F, Silveira  MB,  Ferreira U, Etchebehere Elba CSC. The current role of PET/CT in urological malignancies. Clin Transl Imaging 8, 313–347 (2020). https://doi.org/10.1007/s40336-020-00378-w
  6. Mosci C, Pericole FV, Oliveira GB, Delamain MT, Takahashi MES, Carvalheira JBC, Etchebehere ECSC, Santos AO, Miranda ECM, Lima MCL, Amorim BJ, de Souza CA, Lorand-Metze I, Ramos CD. 99mTc-sestamibi SPECT/CT and 18F-FDG-PET/CT have similar performance but different imaging patterns in newly diagnosed multiple myeloma. Nucl Med Commun. 2020 Oct;41(10):1081-1088. https://doi.org/10.1097/MNM.0000000000001259
  7. Souza S, Delamain M, Tobar N, Castro V, Frasson F, Amorim B, Etchebehere E, Lima M, Mengatti J, Araujo EB, Perini E, De Souza C, Santos A, Lorant-Metze I, Ramos C. Comparison of 68ga-psma and 18f-fdg pet/ct uptake in different lymphoma. Hematol Transfus Cell Ther 2020;42:48. https://doi.org/10.1016/j.htct.2020.09.086
  8. Takahashi MES, Mosci C, Souza EM, Brunetto SQ, Etchebehere E, Santos AO, Camacho MR, Miranda E, Lima MCL, Amorim BJ, de Souza C, Pericole FV, Lorand-Metze I, Ramos CD. Proposal for a Quantitative 18F-FDG PET/CT Metabolic Parameter to Assess the Intensity of Bone Involvement in Multiple Myeloma. Sci Rep. 2019 Nov 11;9(1):16429. https://doi.org/10.1038/s41598-019-52740-2
  9. Brito AE, Santos A, Sasse AD, Cabello C, Oliveira P, Mosci C, Souza T, Amorim B, Lima M, Ramos CD, Etchebehere E. 18F-Fluoride PET/CT tumor burden quantification predicts survival in breast cancer. Oncotarget. 2017 May 30;8(22):36001-36011. https://doi.org/10.18632/oncotarget.16418
  10. Lima MC, de Lima ML, Pepe CF, Etchebehere EC, Santos AO, Amorim BJ, Camargo EE, Ferreira U, Palma PC, Ramos CD. Technetium-99m-L,L-ethylenedicysteine is more effective than technetium-99m diethylenetriamine penta-acetic acid for excluding obstruction in patients with pyelocalicinal dilation. Urology. 2010 Aug;76(2):283-8. https://doi.org/10.1016/j.urology.2009.12.032
Laboratórios de Pesquisa
Fale com a pesquisadora

Contato

Preencha o formulário abaixo para entrar em contato com a pesquisadora.

Endereço

em breve

Telefone

em breve

E-mail

marlima1@unicamp.br

Este website utiliza cookies para aprimorar a experiência
Veja nossa Política de Privacidade para saber mais.
CancerThera
Arraste!